Yasamineh S, et al. An overview on nanoparticle-based strategies to fight viral infections with a focus on COVID-19. J Nanobiotechnol. 2022;20(1):1–26.
Article
Google Scholar
Yasamineh S, et al. Spotlight on therapeutic efficiency of mesenchymal stem cells in viral infections with a focus on COVID-19. Stem Cell Res Ther. 2022;13(1):1–23.
Article
Google Scholar
Yang KS, et al. Evolutionary and structural insights about potential SARS-CoV-2 evasion of nirmatrelvir. J Med Chem. 2022;65(13):8686–98.
Article
CAS
PubMed
Google Scholar
Hu J, et al. The potential use of microRNAs as a therapeutic strategy for SARS-CoV-2 infection. Arch Virol. 2021;166(10):2649–72.
Article
CAS
PubMed
PubMed Central
Google Scholar
Nguyen NHL, et al. COVID-19 spike protein induced phononic modification in antibody-coupled graphene for viral detection application. ACS Nano. 2021;15(7):11743–52.
Article
CAS
PubMed
Google Scholar
Chen RE, et al. Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies. Nat Med. 2021;27(4):717–26.
Article
CAS
PubMed
PubMed Central
Google Scholar
Cosar B, et al. SARS-CoV-2 mutations and their viral variants. Cytokine & growth factor reviews; 2021.
Fan Y, et al. SARS-CoV-2 Omicron variant: recent progress and future perspectives. Signal Transduct Target Ther. 2022;7(1):1–11.
Article
Google Scholar
Shiehzadegan S, et al. Analysis of the delta variant B. 1.617. 2 COVID-19. Clin Pract. 2021;11(4):778–84.
Article
PubMed
PubMed Central
Google Scholar
Brandal LT, et al. Outbreak caused by the SARS-CoV-2 Omicron variant in Norway, November to December 2021. Eurosurveillance. 2021;26(50):2101147.
Article
CAS
PubMed
PubMed Central
Google Scholar
Burki TK. Lifting of COVID-19 restrictions in the UK and the Delta variant. Lancet Respir Med. 2021;9(8):e85.
Article
CAS
PubMed
PubMed Central
Google Scholar
Alexandar S, et al. A comprehensive review on Covid-19 Delta variant. Int J Pharmacol Clin Res (IJPCR). 2021;5(83–85):7.
Google Scholar
He J, et al. Proportion of asymptomatic coronavirus disease 2019: a systematic review and meta-analysis. J Med Virol. 2021;93(2):820–30.
Article
CAS
PubMed
Google Scholar
Nasreen S, et al. Effectiveness of COVID-19 vaccines against symptomatic SARS-CoV-2 infection and severe outcomes with variants of concern in Ontario. Nat Microbiol. 2022;7(3):379–85.
Article
CAS
PubMed
Google Scholar
Murthy SK. Nanoparticles in modern medicine: state of the art and future challenges. Int J Nanomed. 2007;2(2):129.
CAS
Google Scholar
Patra JK, et al. Nano based drug delivery systems: recent developments and future prospects. J Nanobiotechnol. 2018;16(1):1–33.
Article
Google Scholar
Yin IX, et al. The antibacterial mechanism of silver nanoparticles and its application in dentistry. Int J Nanomed. 2020;15:2555–62.
Article
CAS
Google Scholar
Fam SY, et al. Stealth coating of nanoparticles in drug-delivery systems. Nanomaterials. 2020;10(4):787.
Article
CAS
PubMed
PubMed Central
Google Scholar
Li B, et al. The potential of biomimetic nanoparticles for tumor-targeted drug delivery. Nanomedicine. 2018;13(16):2099–118.
Article
CAS
PubMed
Google Scholar
Sportelli MC, et al. Can nanotechnology and materials science help the fight against SARS-CoV-2? Nanomaterials. 2020;10(4):802.
Article
CAS
PubMed
PubMed Central
Google Scholar
Vu MN, et al. Current and future nanoparticle vaccines for COVID-19. EBioMedicine. 2021;74.
Article
CAS
PubMed
PubMed Central
Google Scholar
Chowdhury NK, et al. Nanoparticles as an effective drug delivery system in COVID-19. Biomed Pharmacother. 2021;143.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kusumoputro S, et al. Potential nanoparticle applications for prevention, diagnosis, and treatment of COVID-19. View. 2020;1(4):20200105.
Article
Google Scholar
Norouzi M, et al. Recent advances on nanomaterials-based fluorimetric approaches for microRNAs detection. Mater Sci Eng C. 2019;104:110007.
Article
CAS
Google Scholar
Yasamineh S, et al., A state-of-the-art review on the recent advances of niosomes as a targeted drug delivery system. Int J Pharm. 2022;121878.
Idris A, et al. A SARS-CoV-2 targeted siRNA-nanoparticle therapy for COVID-19. Mol Ther. 2021;29(7):2219–26.
Article
CAS
PubMed
PubMed Central
Google Scholar
Reichmuth AM, et al. mRNA vaccine delivery using lipid nanoparticles. Ther Deliv. 2016;7(5):319–34.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hajj KA, Whitehead KA. Tools for translation: non-viral materials for therapeutic mRNA delivery. Nat Rev Mater. 2017;2(10):1–17.
Article
Google Scholar
Khurana A, et al. Role of nanotechnology behind the success of mRNA vaccines for COVID-19. Nano Today. 2021;38:101142.
Article
CAS
PubMed
PubMed Central
Google Scholar
Billingsley MM, et al. Ionizable lipid nanoparticle-mediated mRNA delivery for Human CAR T Cell Engineering. Nano Lett. 2020;20(3):1578–89.
Article
CAS
PubMed
PubMed Central
Google Scholar
Cullis PR, Hope MJ. Lipid nanoparticle systems for enabling gene therapies. Mol Ther. 2017;25(7):1467–75.
Article
CAS
PubMed
PubMed Central
Google Scholar
Uchida S, et al. Nanomedicine-Based approaches for mRNA delivery. Mol Pharm. 2020;17(10):3654–84.
Article
CAS
PubMed
Google Scholar
Milovanovic M, et al. Antimicrobial nanoarchitectonics. Amsterdam: Elsevier; 2017.
Google Scholar
Yadavalli T, Shukla D. Role of metal and metal oxide nanoparticles as diagnostic and therapeutic tools for highly prevalent viral infections. Nanomed Nanotechnol Biol Med. 2017;13(1):219–30.
Article
CAS
Google Scholar
Chen L, Liang J. An overview of functional nanoparticles as novel emerging antiviral therapeutic agents. Mater Sci Eng C. 2020;112:110924.
Article
CAS
Google Scholar
Dykman LA. Gold nanoparticles for preparation of antibodies and vaccines against infectious diseases. Expert Rev Vaccines. 2020;19(5):465–77.
Article
CAS
PubMed
Google Scholar
Behbudi G. Effect of silver nanoparticles disinfectant on covid-19. Adv Appl NanoBio-Technol. 2021;2(2):63–7.
CAS
Google Scholar
Allawadhi P, et al. Silver nanoparticle based multifunctional approach for combating COVID-19. Sens Int. 2021;2:100101.
Article
PubMed
PubMed Central
Google Scholar
Morris D, et al. Antiviral and immunomodulatory activity of silver nanoparticles in experimental RSV infection. Viruses. 2019;11(8):732.
Article
CAS
PubMed
PubMed Central
Google Scholar
Salleh A, et al. The potential of silver nanoparticles for antiviral and antibacterial applications: a mechanism of action. Nanomaterials, 2020;10(8).
Allawadhi P, et al. Silver nanoparticle based multifunctional approach for combating COVID-19. Sens Int. 2021;100101.
Asgharzadeh F, et al. Therapeutic effects of silver nanoparticle containing sulfasalazine on DSS-induced colitis model. J Drug Deliv Sci Technol. 2021;61:102133.
Article
CAS
Google Scholar
Zachar O. Formulations for COVID-19 treatment via silver nanoparticles inhalation delivery. OSF Prepr. 2020;1–19.
Shaji J, Patole V. Protein and peptide drug delivery: oral approaches. Indian J Pharm Sci. 2008;70(3):269.
Article
PubMed
PubMed Central
Google Scholar
Date AA, Hanes J, Ensign LM. Nanoparticles for oral delivery: design, evaluation and state-of-the-art. J Controll Release. 2016;240:504–26.
Article
CAS
Google Scholar
Lima TLC, et al. Improving encapsulation of hydrophilic chloroquine diphosphate into biodegradable nanoparticles: a promising approach against herpes virus simplex-1 infection. Pharmaceutics. 2018;10(4):255.
Article
CAS
PubMed
PubMed Central
Google Scholar
Pichl L, et al. Magnetic bead technology in viral RNA and DNA extraction from plasma minipools. Transfusion. 2005;45(7):1106–10.
Article
CAS
PubMed
Google Scholar
Chaimayo C, et al. Rapid SARS-CoV-2 antigen detection assay in comparison with real-time RT-PCR assay for laboratory diagnosis of COVID-19 in Thailand. Virol J. 2020;17(1):177.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zhao Z, et al. A simple magnetic nanoparticles-based viral RNA extraction method for efficient detection of SARS-CoV-2. bioRxiv, 2020: p. 2020.02.22.961268.
Ramos-Mandujano G, et al. A robust, safe, and scalable magnetic nanoparticle workflow for RNA extraction of pathogens from clinical and wastewater samples. Glob Chall. 2021;5(4):2000068.
Article
PubMed
PubMed Central
Google Scholar
Hassanzadeh P. Nanotheranostics against COVID-19: from multivalent to immune-targeted materials. J Controll Release. 2020;328:112–26.
Article
CAS
Google Scholar
Mignani S, et al. Functionalized dendrimer platforms as a new forefront arsenal targeting SARS-CoV-2: an opportunity. Pharmaceutics. 2021;13(9):1513.
Article
CAS
PubMed
PubMed Central
Google Scholar
Spitz Steinberg R, et al. Breathable vapor toxicant barriers based on multilayer graphene oxide. ACS Nano. 2017;11(6):5670–9.
Article
CAS
PubMed
Google Scholar
Palmieri V, et al. Face masks and nanotechnology: keep the blue side up. Nano Today. 2021;37:101077.
Article
CAS
PubMed
PubMed Central
Google Scholar
Campos EV, et al. How can nanotechnology help to combat COVID-19? Opportunities and urgent need. J Nanobiotechnol. 2020;18(1):1–23.
Article
Google Scholar
Chintagunta AD, Nalluru S, NS SK. Nanotechnology: an emerging approach to combat COVID-19. Emerg Mater. 2021;4(1):119–30.
Article
CAS
Google Scholar
Pramanik A, et al. The rapid diagnosis and effective inhibition of coronavirus using spike antibody attached gold nanoparticles. Nanoscale Adv. 2021;3(6):1588–96.
Article
CAS
PubMed
PubMed Central
Google Scholar
Chauhan G, et al. Nanotechnology for COVID-19: therapeutics and vaccine research. ACS Nano. 2020;14(7):7760–82.
Article
CAS
PubMed
Google Scholar
Hamdy ME, et al. Development of gold nanoparticles biosensor for ultrasensitive diagnosis of foot and mouth disease virus. J Nanobiotechnol. 2018;16(1):48.
Article
Google Scholar
Dilshad E, et al. Synthesis of functional silver nanoparticles and microparticles with modifiers and evaluation of their antimicrobial, anticancer, and antioxidant activity. J Funct Biomater. 2020;11(4):76.
Article
CAS
PubMed
PubMed Central
Google Scholar
Nayak V, et al. Potentialities of selenium nanoparticles in biomedical science. New J Chem. 2021;45(6):2849–78.
Article
CAS
Google Scholar
Manzano M, Vallet-Regí M. Mesoporous silica nanoparticles for drug delivery. Adv Funct Mater. 2020;30(2):1902634.
Article
CAS
Google Scholar
Kotliarov Y, et al. Broad immune activation underlies shared set point signatures for vaccine responsiveness in healthy individuals and disease activity in patients with lupus. Nat Med. 2020;26(4):618–29.
Article
CAS
PubMed
PubMed Central
Google Scholar
Rostami H, et al. Co-utilization of a TLR5 agonist and nano-formulation of HIV-1 vaccine candidate leads to increased vaccine immunogenicity and decreased immunogenic dose: a preliminary study. Immunol Lett. 2017;187:19–26.
Article
CAS
PubMed
Google Scholar
Kreuter J, Nanoparticles as adjuvants for vaccines. Vaccine Des. 1995;463–472.
Zeng L, et al. Broad-spectrum CRISPR-mediated inhibition of SARS-CoV-2 variants and endemic coronaviruses in vitro. Nat Commun. 2022;13(1):1–16.
Article
CAS
Google Scholar
Jaber N, et al. A review of the antiviral activity of Chitosan, including patented applications and its potential use against COVID-19. J Appl Microbiol. 2022;132(1):41–58.
Article
CAS
PubMed
Google Scholar
Hanafy NA, El-Kemary MA. Silymarin/curcumin loaded albumin nanoparticles coated by chitosan as muco-inhalable delivery system observing anti-inflammatory and anti COVID-19 characterizations in oleic acid triggered lung injury and in vitro COVID-19 experiment. Int J Biol Macromol. 2022;198:101–10.
Article
CAS
PubMed
Google Scholar
Parisi OI, et al. Design and development of plastic antibodies against SARS-CoV-2 RBD based on molecularly imprinted polymers that inhibit in vitro virus infection. Nanoscale. 2021;13(40):16885–99.
Article
CAS
PubMed
Google Scholar
de Barros AODS, et al. Polymeric nanoparticles and nanomicelles of hydroxychloroquine co-loaded with azithromycin potentiate anti-SARS-CoV-2 effect. J Nanostruct Chem. 2022;1–19.
Baldassi D, et al. Inhibition of SARS-CoV-2 replication in the lung with siRNA/VIPER polyplexes. J Controll Release. 2022;345:661–74.
Article
CAS
Google Scholar
Rungrojcharoenkit K, et al. Development of an adjuvanted nanoparticle vaccine against influenza virus, an in vitro study. PLoS One. 2020;15(8):e0237218.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wang J, et al. Pulmonary surfactant–biomimetic nanoparticles potentiate heterosubtypic influenza immunity. Science 2020;367(6480).
Ghaffari H, et al. Inhibition of H1N1 influenza virus infection by zinc oxide nanoparticles: another emerging application of nanomedicine. J Biomed Sci. 2019;26(1):1–10.
Article
CAS
Google Scholar
Xiang D, et al. Inhibition of A/Human/Hubei/3/2005 (H3N2) influenza virus infection by silver nanoparticles in vitro and in vivo. Int J Nanomed. 2013;8:4103.
Article
Google Scholar
Li Y, et al. Inhibition of H1N1 influenza virus-induced apoptosis by selenium nanoparticles functionalized with arbidol through ROS-mediated signaling pathways. J Mater Chem B. 2019;7(27):4252–62.
Article
CAS
Google Scholar
Kumar R, et al. Iron oxide nanoparticles based antiviral activity of H1N1 influenza a virus. J Infect Chemother. 2019;25(5):325–9.
Article
CAS
PubMed
Google Scholar
Law S, et al. Could curcumin modified silver nanoparticles treat COVID-19? Adv Pharm Bull. 2022;12(1):5.
PubMed
Google Scholar
Xiao M-F, et al. Applications of nanomaterials in COVID-19 pandemic. Rare Metals 2021;1–13.
Mallakpour S, Azadi E, Hussain CM. The latest strategies in the fight against the COVID-19 pandemic: the role of metal and metal oxide nanoparticles. New J Chem. 2021;45(14):6167–79.
Article
CAS
Google Scholar
Rai M, et al. Nanotechnology-based promising strategies for the management of COVID-19: current development and constraints. Expert Rev Anti-infect Ther. 2022;20(10):1299–308.
Article
CAS
PubMed
Google Scholar
Lin N, et al. Antiviral nanoparticles for sanitizing surfaces: a roadmap to self-sterilizing against COVID-19. Nano Today. 2021;40:101267.
Article
CAS
PubMed
PubMed Central
Google Scholar
Al-Radadi NS, Abu-Dief AM. Silver nanoparticles (AgNPs) as a metal nano-therapy: possible mechanisms of antiviral action against COVID-19. Inorg Nano-Metal Chem. 2022;1–19.
Mehranfar A, Izadyar M. Theoretical design of functionalized gold nanoparticles as antiviral agents against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). J Phys Chem Lett. 2020;11(24):10284–9.
Article
CAS
PubMed
PubMed Central
Google Scholar
Palmieri V, Papi M. Can graphene take part in the fight against COVID-19? Nano Today. 2020;33:100883.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ferrari AC, et al. Science and technology roadmap for graphene, related two-dimensional crystals, and hybrid systems. Nanoscale. 2015;7(11):4598–810.
Article
CAS
PubMed
Google Scholar
Chauhan N, Maekawa T, Kumar DNS. Graphene based biosensors—accelerating medical diagnostics to new-dimensions. J Mater Res. 2017;32(15):2860–82.
Article
CAS
Google Scholar
Lee S, et al. Carbon nanotube mask filters and their hydrophobic barrier and hyperthermic antiviral effects on SARS-CoV-2. ACS Appl Nano Mater. 2021;4(8):8135–44.
Article
CAS
Google Scholar
Song Z, et al. Virus capture and destruction by label-free graphene oxide for detection and disinfection applications. Small. 2015;11(9–10):1171–6.
Article
CAS
PubMed
Google Scholar
Ullah S, et al. Reusability comparison of melt-blown vs nanofiber face mask filters for use in the coronavirus pandemic. ACS Appl Nano Mater. 2020;3(7):7231–41.
Article
CAS
Google Scholar
Zhong H, et al. Reusable and recyclable graphene masks with outstanding superhydrophobic and photothermal performances. ACS Nano. 2020;14(5):6213–21.
Article
CAS
PubMed
Google Scholar
Lombardo D, Kiselev MA, Caccamo MT. Smart nanoparticles for drug delivery application: development of versatile nanocarrier platforms in biotechnology and nanomedicine. J Nanomater. 2019;2019.
Eatemadi A, et al. Carbon nanotubes: properties, synthesis, purification, and medical applications. Nanoscale Res Lett. 2014;9(1):1–13.
Article
CAS
Google Scholar
Son KH, Hong JH, Lee JW. Carbon nanotubes as cancer therapeutic carriers and mediators. Int J Nanomed. 2016;11:5163.
Article
CAS
Google Scholar
Zhu S, et al. Anti-betanodavirus activity of isoprinosine and improved efficacy using carbon nanotubes based drug delivery system. Aquaculture. 2019;512:734377.
Article
CAS
Google Scholar
Mohajeri M, Behnam B, Sahebkar A. Biomedical applications of carbon nanomaterials: drug and gene delivery potentials. J Cell Physiol. 2019;234(1):298–319.
Article
CAS
Google Scholar
Zou Z, Yao M. Airflow resistance and bio-filtering performance of carbon nanotube filters and current facepiece respirators. J Aerosol Sci. 2015;79:61–71.
Article
CAS
Google Scholar
Vo E, et al. Application of direct-reading and elemental carbon analysis methods to measure mass-based penetration of carbon nanotubes through elastomeric half-face and filtering facepiece respirators. Aerosol Sci Technol. 2016;50(10):1044–54.
Article
CAS
PubMed
PubMed Central
Google Scholar
Vo E, et al. Measurement of mass-based carbon nanotube penetration through filtering facepiece respirator filtering media. Ann Occup Hyg. 2014;58(5):646–56.
CAS
PubMed
PubMed Central
Google Scholar
Van Doremalen N, et al. Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. N Engl J Med. 2020;382(16):1564–7.
Article
PubMed
Google Scholar
Wang L, Hu C, Shao L. The antimicrobial activity of nanoparticles: present situation and prospects for the future. Int J Nanomed. 2017;12:1227.
Article
CAS
Google Scholar
Hamouda T, et al. Preparation of cellulose-based wipes treated with antimicrobial and antiviral silver nanoparticles as novel effective high-performance coronavirus fighter. Int J Biol Macromol. 2021;181:990–1002.
Article
CAS
PubMed
PubMed Central
Google Scholar
Siadati SA, Afzali M, Sayyadi M. Could silver nano-particles control the 2019-nCoV virus?; An urgent glance to the past. Chem Rev Lett. 2020;3(1):9–11.
CAS
Google Scholar
Panda S, et al. 2D MXenes for combatting COVID-19 pandemic: a perspective on latest developments and innovations. FlatChem. 2022;33:100377.
Article
CAS
PubMed Central
Google Scholar
Huang Z, et al. Continuous synthesis of size-tunable silver nanoparticles by a green electrolysis method and multi-electrode design for high yield. J Mater Chem A. 2015;3(5):1925–9.
Article
CAS
Google Scholar
Kampf G, et al. Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents. J Hosp Infect. 2020;104(3):246–51.
Article
CAS
PubMed
PubMed Central
Google Scholar
Dey B, Engley F Jr. Neutralization of antimicrobial chemicals by recovery media. J Microbiol Methods. 1994;19(1):51–8.
Article
CAS
Google Scholar
Logothetidis S. Nanostructured materials and their applications. Cham: Springer Science & Business Media; 2012.
Book
Google Scholar
Maynard AD. A research strategy for addressing risk nanotechnology. Woodrow Wilson Int Center Sch. 2006;444:267–9.
CAS
Google Scholar
Destache CJ, et al. Combination antiretroviral drugs in PLGA nanoparticle for HIV-1. BMC Infect Dis. 2009;9(1):1–8.
Article
Google Scholar
Shibata A, et al. Polymeric nanoparticles containing combination antiretroviral drugs for HIV type 1 treatment. AIDS Res Hum Retrovir. 2013;29(5):746–54.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hu B, Huang S, Yin L. The cytokine storm and COVID-19. J Med Virol. 2021;93(1):250–6.
Article
CAS
PubMed
Google Scholar
Arnaldez FI, et al. The Society for Immunotherapy of Cancer perspective on regulation of interleukin-6 signaling in COVID-19-related systemic inflammatory response. J Immunother Cancer 2020;8(1).
Zhou G, Chen S, Chen Z. Advances in COVID-19: the virus, the pathogenesis, and evidence-based control and therapeutic strategies. Front Med. 2020;14(2):117–25.
Article
PubMed
PubMed Central
Google Scholar
Tufan A, Güler AA, Matucci-Cerinic M. COVID-19, immune system response, hyperinflammation and repurposing antirheumatic drugs. Turk J Med Sci. 2020;50(SI-1):620–32.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ahmadpoor P, Rostaing L. Why the immune system fails to mount an adaptive immune response to a Covid-19 infection. Transpl Int. 2020;33(7):824–5.
Article
PubMed
Google Scholar
Fung S-Y, et al. A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: lessons from other pathogenic viruses. Emerg Microbes Infect. 2020;9(1):558–70.
Article
CAS
PubMed
Google Scholar
Aghbash PS, et al. SARS-CoV-2 infection: the role of PD-1/PD-L1 and CTLA-4 axis. Life Sci. 2021;270:119124.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bahmani M, et al. Severe acute respiratory syndrome coronavirus 2 infection: role of interleukin-6 and the inflammatory cascade. World J Virol. 2022;11(3):113.
Article
PubMed
PubMed Central
Google Scholar
Tang Y, et al. Cytokine storm in COVID-19: the current evidence and treatment strategies. Front Immunol. 2020;1708.
Debouttière P, et al. a. Favre-Réguillon, Y. Lin, S. Pellet-Rostaing, R. Lamartine, P. Perriat and O. Tillement. Adv Funct Mater. 2006;16(18):2330–9.
Article
Google Scholar
Perez JM, et al. Viral-induced self-assembly of magnetic nanoparticles allows the detection of viral particles in biological media. J Am Chem Soc. 2003;125(34):10192–3.
Article
CAS
PubMed
Google Scholar
Xu X, et al. Effective treatment of severe COVID-19 patients with tocilizumab. Proc Natl Acad Sci. 2020;117(20):10970–5.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zhang Q, et al. Recent progress in capturing and neutralizing inflammatory cytokines. CCS Chem. 2020;2(3):376–89.
Article
CAS
Google Scholar
Lima AC, et al. Interleukin-6 neutralization by antibodies immobilized at the surface of polymeric nanoparticles as a therapeutic strategy for arthritic diseases. ACS Appl Mater Interfaces. 2018;10(16):13839–50.
Article
CAS
PubMed
Google Scholar
Thamphiwatana S, et al. Macrophage-like nanoparticles concurrently absorbing endotoxins and proinflammatory cytokines for sepsis management. Proc Natl Acad Sci. 2017;114(43):11488–93.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zhang Q, et al. Neutrophil membrane-coated nanoparticles inhibit synovial inflammation and alleviate joint damage in inflammatory arthritis. Nat Nanotechnol. 2018;13(12):1182–90.
Article
CAS
PubMed
Google Scholar
Abo-zeid Y, et al. A molecular docking study repurposes FDA approved iron oxide nanoparticles to treat and control COVID-19 infection. Eur J Pharm Sci. 2020;153:105465.
Article
CAS
PubMed
PubMed Central
Google Scholar
Vorobjeva NV, Chernyak BV. NETosis: molecular mechanisms, role in physiology and pathology. Biochemistry (Mosc). 2020;85(10):1178–90.
Article
CAS
PubMed
Google Scholar
Zaim S, et al. COVID-19 and multiorgan response. Curr Probl Cardiol. 2020;45(8):100618.
Article
PubMed
PubMed Central
Google Scholar
Park HH, et al. PEGylated nanoparticle albumin-bound steroidal ginsenoside derivatives ameliorate SARS-CoV-2-mediated hyper-inflammatory responses. Biomaterials. 2021;273:120827.
Article
CAS
PubMed
PubMed Central
Google Scholar
Rejinold NS, et al. Injectable niclosamide nanohybrid as an anti-SARS-CoV-2 strategy. Colloids Surf B. 2021;208:112063.
Article
CAS
Google Scholar
Rejinold N, et al. Bovine serum albumin-coated niclosamide-zein nanoparticles as potential injectable medicine against COVID-19. Materials. 2021;14(14):3792.
Article
Google Scholar
Yamaoka-Tojo M. Vascular endothelial glycocalyx damage in COVID-19. Int J Mol Sci. 2020;21(24):9712.
Article
CAS
PubMed
PubMed Central
Google Scholar
Abo-Seidaa OM, et al. The effect of nanoparticles and electromagnetic waves on Coronavirus (COVID-19) using a rectangular waveguide cavity resonator.
Zachar O. Formulations for COVID-19 early stage treatment via silver nanoparticles inhalation delivery at home and hospital. ScienceOpen Preprints; 2020.
Tu Y-F, et al. A review of SARS-CoV-2 and the ongoing clinical trials. Int J Mol Sci. 2020;21(7):2657.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wang H, et al. Development of an inactivated vaccine candidate, BBIBP-CorV, with potent protection against SARS-CoV-2. Cell. 2020;182(3):713–21.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bavel JJV, et al. Using social and behavioural science to support COVID-19 pandemic response. Nat Hum Behav. 2020;4(5):460–71.
Article
PubMed
Google Scholar
Allam M, et al. COVID-19 diagnostics, tools, and prevention. Diagnostics. 2020;10(6):409.
Article
CAS
PubMed
PubMed Central
Google Scholar
Scarabel L, et al. Pharmacological strategies to prevent SARS-CoV-2 infection and treat the early phases of COVID-19. Int J Infect Dis. 2021;104:441–51.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zaki MM, et al. Cell therapy strategies for COVID-19: current approaches and potential applications. Sci Adv. 2021;7(33):eabg5995.
Article
PubMed
PubMed Central
Google Scholar
Krammer F. SARS-CoV-2 vaccines in development. Nature 2020;1–16.
Dong Y, et al. A systematic review of SARS-CoV-2 vaccine candidates. Signal Transduct Target ther. 2020;5(1):1–14.
Article
Google Scholar
Gao Q, et al. Development of an inactivated vaccine candidate for SARS-CoV-2. Science 2020.
Ozdilek A, Avci FY. Glycosylation as a key parameter in the design of nucleic acid vaccines. Curr Opin Struct Biol. 2022;73:102348.
Article
CAS
PubMed
Google Scholar
Chavda VP, et al. Nucleic acid vaccines for COVID-19: a paradigm shift in the vaccine development arena. Biologics. 2021;1(3):337–56.
Article
Google Scholar
McCann N, et al. Viral vector vaccines. Curr Opin Immunol. 2022;77:102210.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ura T, Okuda K, Shimada M. Developments in viral vector-based vaccines. Vaccines. 2014;2(3):624–41.
Article
PubMed
PubMed Central
Google Scholar
Heidary M, et al. A comprehensive review of the protein subunit vaccines against COVID-19. Front Microbiol. 2022;13:927306.
Article
PubMed
PubMed Central
Google Scholar
Palacios R, et al. Double-Blind, randomized, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of treating Healthcare Professionals with the Adsorbed COVID-19 (inactivated) vaccine manufactured by Sinovac–PROFISCOV: a structured summary of a study protocol for a randomised controlled trial. Trials. 2020;21(1):1–3.
Article
Google Scholar
Bell BP. ACIP COVID-19 Vaccines Work Group 2020.
van Doremalen N, et al., ChAdOx1 nCoV-19 vaccination prevents SARS-CoV-2 pneumonia in rhesus macaques. bioRxiv, 2020.
Ramasamy MN, et al. Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial. Lancet 2020.
Mercado NB, et al. Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques. Nature. 2020;586(7830):583–8.
Article
CAS
PubMed
PubMed Central
Google Scholar
Poland GA, Ovsyannikova IG, Kennedy RB. SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates. Lancet 2020.
Raja AT, Alshamsan A, Al-Jedai A. Status of the current COVID-19 vaccine candidates: implications in the Saudi Population. Saudi Pharm J. 2020.
Jackson LA, et al. An mRNA vaccine against SARS-CoV-2—preliminary report. N Engl J Med. 2020;383(20):1920–31.
Article
CAS
PubMed
Google Scholar
Mulligan MJ, et al. Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults. Nature. 2020;586(7830):589–93.
Article
CAS
PubMed
Google Scholar
Rawat K, Kumari P, Saha L. COVID-19 vaccine: a recent update in pipeline vaccines, their design and development strategies. Eur J Pharmacol. 2020;173751.
López-Sagaseta J, et al. Self-assembling protein nanoparticles in the design of vaccines. Comput Struct Biotechnol J. 2016;14:58–68.
Article
PubMed
Google Scholar
Hajj Hussein I, et al. Vaccines through centuries: major Cornerstones of Global Health. Front Public Health 2015;3.
Bayat M, Asemani Y, Najafi S. Essential considerations during vaccine design against COVID-19 and review of pioneering vaccine candidate platforms. Int Immunopharmacol. 2021;97:107679.
Article
CAS
PubMed
PubMed Central
Google Scholar
Evans ER, et al. Metallic nanoparticles for cancer immunotherapy. Mater Today. 2018;21(6):673–85.
Article
CAS
Google Scholar
Smith JD, Morton LD, Ulery BD. Nanoparticles as synthetic vaccines. Curr Opin Biotechnol. 2015;34:217–24.
Article
CAS
PubMed
Google Scholar
Chintagunta AD, Nalluru S, NS SK, Nanotechnology: an emerging approach to combat COVID-19. Emerg Mater. 2021;1–12.
Chandler M, et al. Innate immune responses triggered by nucleic acids inspire the design of immunomodulatory nucleic acid nanoparticles (NANPs). Curr Opin Biotechnol. 2020;63:8–15.
Article
CAS
PubMed
Google Scholar
Pardi N, et al. mRNA vaccines—a new era in vaccinology. Nat Rev Drug Discov. 2018;17(4):261–79.
Article
CAS
PubMed
PubMed Central
Google Scholar
Schlich M, et al. Cytosolic delivery of nucleic acids: the case of ionizable lipid nanoparticles. Bioeng Transl Med. 2021;6(2):e10213.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kreimer AR, et al. Evidence for single-dose protection by the bivalent HPV vaccine—review of the Costa Rica HPV vaccine trial and future research studies. Vaccine. 2018;36(32):4774–82.
Article
PubMed
PubMed Central
Google Scholar
Deng Y, et al. Rational development of a polysaccharide–protein-conjugated nanoparticle vaccine against SARS‐CoV‐2 variants and Streptococcus pneumoniae. Adv Mater. 2022;2200443.
Song JY, et al. Safety and immunogenicity of a SARS-CoV-2 recombinant protein nanoparticle vaccine (GBP510) adjuvanted with AS03: a randomised, placebo-controlled, observer-blinded phase 1/2 trial. EClinicalMedicine. 2022;51:101569.
Article
PubMed
PubMed Central
Google Scholar
Johnston SC, et al. A SARS-CoV-2 spike ferritin nanoparticle vaccine is protective and promotes a strong immunological response in the cynomolgus macaque coronavirus disease 2019 (COVID-19) model. Vaccines. 2022;10(5):717.
Article
CAS
PubMed
PubMed Central
Google Scholar
Udugama B, et al. Diagnosing COVID-19: the disease and tools for detection. ACS Nano. 2020;14(4):3822–35.
Article
CAS
PubMed
Google Scholar
Roewe J, et al. Bacterial polyphosphates interfere with the innate host defense to infection. Nat Commun. 2020;11(1):4035.
Article
CAS
PubMed
PubMed Central
Google Scholar
Palestino G, et al. Can nanotechnology help in the fight against COVID-19? Expert Rev Anti Infect Ther. 2020;18(9):849–64.
Article
CAS
PubMed
Google Scholar
Puri N, et al. Synthesis and characterization of reduced graphene oxide supported gold nanoparticles-poly(pyrrole-co-pyrrolepropylic acid) nanocomposite-based electrochemical biosensor. Appl Biochem Biotechnol. 2014;174(3):911–25.
Article
CAS
PubMed
Google Scholar
Weiss C, et al. Toward nanotechnology-enabled approaches against the COVID-19 pandemic. ACS Nano. 2020;14(6):6383–406.
Article
CAS
PubMed
Google Scholar
Seo G, et al. Rapid detection of COVID-19 causative virus (SARS-CoV-2) in human nasopharyngeal swab specimens using field-effect transistor-based biosensor. ACS Nano. 2020;14(4):5135–42.
Article
CAS
PubMed
Google Scholar
Vaquer A, et al. Nanoparticle transfer biosensors for the non-invasive detection of SARS-CoV-2 antigens trapped in Surgical Face Masks. Sens Actuators B Chem 2021;130347.
Corman VM, et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Eurosurveillance. 2020;25(3):2000045.
Article
PubMed
PubMed Central
Google Scholar
Chu DK, et al. Molecular diagnosis of a novel coronavirus (2019-nCoV) causing an outbreak of pneumonia. Clin Chem. 2020;66(4):549–55.
Article
PubMed
PubMed Central
Google Scholar
Wang Z, et al. A point-of-care selenium nanoparticle-based test for the combined detection of anti-SARS-CoV-2 IgM and IgG in human serum and blood. Lab Chip. 2020;20(22):4255–61.
Article
CAS
PubMed
Google Scholar
Zhu X, et al. Reverse transcription loop-mediated isothermal amplification combined with nanoparticles-based biosensor for diagnosis of COVID-19. MedRxiv, 2020.
Li S, et al. Highly sensitive and specific diagnosis of COVID-19 by reverse transcription multiple cross-displacement amplification-labelled nanoparticles biosensor. Eur Respir J. 2020;56(6).
Zhu X, et al. Multiplex reverse transcription loop-mediated isothermal amplification combined with nanoparticle-based lateral flow biosensor for the diagnosis of COVID-19. Biosens Bioelectron. 2020;166:112437.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hoffmann M, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181(2):271–80.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ou X, et al. Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV. Nat Commun. 2020;11(1):1–12.
Article
Google Scholar
Ting D, et al. Multisite inhibitors for enteric coronavirus: antiviral cationic carbon dots based on curcumin. ACS Appl Nano Mater. 2018;1(10):5451–9.
Article
Google Scholar
Ngan DK, et al. Repurposing drugs as COVID-19 therapies: a toxicity evaluation. Drug Discov Today 2022.
Gautret P, et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 2020;56(1):105949.
Article
CAS
PubMed
PubMed Central
Google Scholar
Mehra MR, et al. RETRACTED: hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis. Elsevier; 2020.
Elavarasi A, et al. Chloroquine and hydroxychloroquine for the treatment of COVID-19: a systematic review and meta-analysis. J Gen Intern Med. 2020;35(11):3308–14.
Article
PubMed
PubMed Central
Google Scholar
Patel TK, et al. Efficacy and safety of lopinavir-ritonavir in COVID-19: a systematic review of randomized controlled trials. J Infect Public Health. 2021;14(6):740–8.
Article
PubMed
PubMed Central
Google Scholar
Menéndez JC. Approaches to the potential therapy of COVID-19: a general overview from the medicinal chemistry perspective. Molecules. 2022;27(3):658.
Article
PubMed
PubMed Central
Google Scholar
Cao B, et al. A trial of lopinavir–ritonavir in adults hospitalized with severe Covid-19. N Engl J Med. 2020.
Costanzo M, De Giglio MA, Roviello GN. SARS-CoV-2: recent reports on antiviral therapies based on lopinavir/ritonavir, darunavir/umifenovir, hydroxychloroquine, remdesivir, favipiravir and other drugs for the treatment of the new coronavirus. Curr Med Chem. 2020;27(27):4536–41.
Article
CAS
PubMed
Google Scholar
Cai Q, et al. Experimental treatment with favipiravir for COVID-19: an open-label control study. Engineering (Beijing). 2020;6(10):1192–8.
CAS
PubMed
Google Scholar
Ivashchenko AA, et al. Effect of aprotinin and Avifavir® combination therapy for moderate COVID-19 patients. Viruses. 2021;13(7):1253.
Article
CAS
PubMed
PubMed Central
Google Scholar
McClements J, et al. Molecularly imprinted polymer nanoparticles enable rapid, reliable, and robust point-of-care thermal detection of SARS-CoV-2. ACS Sens. 2022;7(4):1122–31.
Article
PubMed
PubMed Central
Google Scholar
Hubbard LR, et al. Detection of SARS-COV-2 by functionally imprinted micelles MRS communications. 2022;1–8.
Khurana A, et al. Superoxide dismutase mimetic nanoceria restrains cerulein induced acute pancreatitis. Nanomedicine. 2019;14(14):1805–25.
Article
CAS
PubMed
Google Scholar
Kumar GS, et al. Selenium nanoparticles involve HSP-70 and SIRT1 in preventing the progression of type 1 diabetic nephropathy. Chemico-Biol Interact. 2014;223:125–33.
Article
CAS
Google Scholar
Kirwale S, et al. Selenium nanoparticles induce autophagy mediated cell death in human keratinocytes. Nanomedicine. 2019;14(15):1991–2010.
Article
CAS
PubMed
Google Scholar
De M, Ghosh PS, Rotello VM. Applications of nanoparticles in biology. Adv Mater. 2008;20(22):4225–41.
Article
CAS
Google Scholar
Islam NU, et al. A multi-target therapeutic potential of Prunus domestica gum stabilized nanoparticles exhibited prospective anticancer, antibacterial, urease-inhibition, anti-inflammatory and analgesic properties. BMC Complement Altern Med. 2017;17(1):276.
Article
PubMed
PubMed Central
Google Scholar
Yusuf A, Casey A. Surface modification of silver nanoparticle (AgNP) by liposomal encapsulation mitigates AgNP-induced inflammation. Toxicol In Vitro. 2019;61:104641.
Article
CAS
PubMed
Google Scholar
Khurana A, et al. Superoxide dismutase mimetic nanoceria restrains cerulein induced acute pancreatitis. Nanomedicine (Lond). 2019;14(14):1805–25.
Article
CAS
PubMed
Google Scholar
Mansour HH, Eid M, El-Arnaouty MB. Effect of silver nanoparticles synthesized by gamma radiation on the cytotoxicity of doxorubicin in human cancer cell lines and experimental animals. Hum Exp Toxicol. 2017;37(1):38–50.
Article
PubMed
Google Scholar
Allawadhi P, et al. Nanoceria as a possible agent for the management of COVID-19. Nano Today. 2020;35:100982.
Article
CAS
PubMed
PubMed Central
Google Scholar
Allawadhi P, et al. Potential of electric stimulation for the management of COVID-19. Med Hypotheses. 2020;144:110259.
Article
CAS
PubMed
PubMed Central
Google Scholar
Khurana A, et al. Yttrium oxide nanoparticles reduce the severity of acute pancreatitis caused by cerulein hyperstimulation. Nanomed Nanotechnol Biol Med. 2019;18:54–65.
Article
CAS
Google Scholar
Sun J, et al. Characterization and evaluation of a novel silver nanoparticles-loaded polymethyl methacrylate denture base: in vitro and < i > in vivo animal study. Dent Mater J. 2021;40(5):1100–8.
Article
CAS
PubMed
Google Scholar
Lu H, et al. Modulatory role of silver nanoparticles and mesenchymal stem cell-derived exosome-modified barrier membrane on macrophages and osteogenesis. Front Chem. 2021. https://doi.org/10.3389/fchem.2021.699802.
Article
PubMed
PubMed Central
Google Scholar
Gonzalez-Carter DA, et al. Silver nanoparticles reduce brain inflammation and related neurotoxicity through induction of H2S-synthesizing enzymes. Sci Rep. 2017;7(1):42871.
Article
PubMed
PubMed Central
Google Scholar
Hebeish A, et al. Antimicrobial wound dressing and anti-inflammatory efficacy of silver nanoparticles. Int J Biol Macromol. 2014;65:509–15.
Article
CAS
PubMed
Google Scholar